FinTrust Capital Advisors’s Celgene Corp CELG Stock Holding History

FinTrust Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,121	Closed	-$707K	–	1153
2019 Q3	$707K	Sell	7,121 -46	-0.6%	-$4.37K	0.24%	83
2019 Q2	$662K	Buy	7,167 +5,177	+260%	+$492K	0.26%	77
2019 Q1	$188K	Sell	1,990 -36	-2%	-$3.15K	0.08%	196
2018 Q4	$130K	Buy	+2,026	New	+$150K	0.06%	234

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

FinTrust Capital Advisors's CELG Position: Q4 2019 in Review

FinTrust Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,121 shares — an estimated $707K sold.

FinTrust Capital Advisors first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $707K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

FinTrust Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
FinTrust Capital Advisors sold 7,121 Celgene Corp shares in Q4 2019, an estimated $707K.
FinTrust Capital Advisors first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
FinTrust Capital Advisors's Celgene Corp position peaked at $707K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on FinTrust Capital Advisors's 13F filing for Q4 2019, filed 23 Jan 2020.